UC Davis Comprehensive Cancer Center
Add to Favorites Newsroom RSS Share
Sacramento, CA USA

Our News on Newswise

Second Cancers Deadlier in Young Patients


Second cancers in children and adolescents and young adults (AYA) are far deadlier than they are in older adults and may partially account for the relatively poor outcomes of cancer patients ages 15-39 overall, a new study by UC Davis researchers...
18-Apr-2017 2:00 PM EDT Add to Favorites

Hitting Cancer with High-Intensity Ultrasound and Immunotherapy


In a new study published today in JCI Insight, UC Davis researchers have shown that combining high-intensity focused ultrasound with two immunotherapies (a PD-1 checkpoint inhibitor and TLR9 agonist) can produce excellent response rates in mouse...
23-Mar-2017 3:05 PM EDT Add to Favorites

UC Davis and Nation's Cancer Centers Jointly Endorse Updated HPV Vaccine Recommendations


Recognizing a critical need to improve national vaccination rates for the human papillomavirus (HPV), UC Davis Comprehensive Cancer Center has again united with each of the 69 National Cancer Institute (NCI)-designated cancer centers in issuing a...
17-Jan-2017 2:05 PM EST Add to Favorites

Terminally Ill Cancer Patients Fare Poorly After Surgery


Patients with disseminated advanced cancer who undergo surgery are far more likely to endure long hospital stays and readmissions, referrals to extended care facilities and death, UC Davis researchers have found.
24-Oct-2016 4:05 PM EDT Add to Favorites

Sexual Pain in Women After Cancer Is Common, and Too Often Ignored


Painful sex in women after cancer treatment is relatively common, often treatable and needs to be addressed by medical providers, a UC Davis oncologist and researcher suggests.
24-Oct-2016 3:05 PM EDT Add to Favorites

Lay Educators Help Boost Colorectal Screening Rates in Hmong


Hmong Americans are more likely to understand the importance of colorectal cancer screening and to get screened when they’re provided information by specially trained Hmong lay health educators, new research from UC Davis has found.
26-Aug-2016 9:00 AM EDT Add to Favorites

Hybrid Treatment Hunts Down and Kills Leukemia Cells

Researchers at UC Davis and Ionis Pharmaceuticals have developed a hybrid treatment that harnesses a monoclonal antibody to deliver antisense DNA to acute lymphoblastic leukemia (ALL) cells and that may lead to less toxic treatments for the disease.
28-Jul-2016 2:05 PM EDT Add to Favorites

Miglioretti Awarded $7.5 Million to Evaluate Supplemental Breast Imaging

Diana Miglioretti, UC Davis dean’s professor of biostatistics and an internationally recognized breast cancer screening expert, has received $7.5 million to determine the effectiveness of two supplemental breast screening and diagnostic workup...
25-May-2016 4:05 PM EDT Add to Favorites

Our YouTube Videos

Chat now!